Specialist in Gastrointestinal Medicines
SLA Pharma AG is a niche biopharmaceutical company, specializing in gastrointestinal and allied disorders, with products in clinical development and already approved for human use. SLA Pharma AG is committed to improving the range of products available to treat gastrointestinal diseases worldwide.
SLA Pharma AG experience in gastroenterology and allied diseases
SLA Pharma AG is one of the few pharmaceutical companies in the world focused solely on developing medicines for the prevention and treatment of gastrointestinal (GI) disorders such as familial adenomatous polyposis (FAP), non-healing pilonidal sinus (PNS), anal fissures and inflammatory
bowel disease.
This commitment to developing solutions for GI disorders has made SLA Pharma AG a world leader in the field with unequalled development, medical, regulatory and commercial expertise in the therapeutic area.
SLA Pharma AG products
SLA Pharma AG pipeline is growing all the time. SLA Pharma AG has developed a product pipeline covering a host of gastrointestinal conditions including familial adenomatous polyposis, anal fissures and inflammatory bowel disease.
SLA Pharma AG network
SLA Pharma AG works closely alongside a global network of top gastroenterologists and colorectal surgeons.
Collaboration with external partners is a core competence of SLA Pharma AG, who have a willingness to establish strategic partnerships for successful in-licensing or out-licensing initiatives.
Contact
For patient, healthcare professional and other enquiries.
Head Office
UK Office
3a Chestnut House
Farm Close, Shenley
Hertfordshire
WD7 9AD
United Kingdom
